S&P 500   3,841.94
DOW   31,496.30
QQQ   308.68
pixel
S&P 500   3,841.94
DOW   31,496.30
QQQ   308.68
pixel
S&P 500   3,841.94
DOW   31,496.30
QQQ   308.68
pixel
S&P 500   3,841.94
DOW   31,496.30
QQQ   308.68
pixel
Log in
NYSE:ABT

Abbott Laboratories Earnings Date, Estimates & History

$117.25
+1.24 (+1.07 %)
(As of 03/5/2021 12:00 AM ET)
Add
Compare
Today's Range
$114.80
Now: $117.25
$117.58
50-Day Range
$110.04
MA: $120.26
$128.23
52-Week Range
$61.61
Now: $117.25
$128.54
Volume4.65 million shs
Average Volume5.28 million shs
Market Capitalization$207.71 billion
P/E Ratio62.04
Dividend Yield1.51%
Beta0.83

Earnings

Abbott Laboratories (NYSE:ABT) Earnings Information

Abbott Laboratories last issued its earnings data on January 26th, 2021. The healthcare product maker reported $1.45 earnings per share for the quarter, topping the consensus estimate of $1.35 by $0.10. The business earned $10.70 billion during the quarter, compared to analyst estimates of $9.94 billion. Its revenue was up 28.7% on a year-over-year basis. Abbott Laboratories has generated $3.24 earnings per share over the last year and currently has a price-to-earnings ratio of 62.0. Abbott Laboratories has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, April 15th, 2021 based off prior year's report dates.

Abbott Laboratories Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

Abbott Laboratories (NYSE:ABT) Earnings Estimates

2021 EPS Consensus Estimate: $5.04
2022 EPS Consensus Estimate: $5.49
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20213$1.35$1.43$1.38
Q2 20213$1.29$1.38$1.33
Q3 20213$1.16$1.21$1.18
Q4 20213$1.12$1.17$1.15
Q1 20222$1.21$1.35$1.28
Q2 20222$1.28$1.35$1.32
Q3 20222$1.37$1.45$1.41
Q4 20222$1.42$1.55$1.49

Abbott Laboratories (NYSE ABT) Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSGAAP EPSRevenue EstimateActual RevenueConference CallDetails
4/15/2021
(Estimated)
       
1/26/202112/31/2020$1.35$1.45$1.70$9.94 billion$10.70 billionTranscript
10/21/20209/30/2020$0.90$0.98$1.27$8.53 billion$8.85 billionTranscript
7/16/20206/30/2020$0.42$0.57$0.84$6.85 billion$7.33 billionTranscript
4/16/20203/31/2020$0.58$0.65$0.99$7.47 billion$7.73 billionTranscript
1/22/2020Q4 19$0.95$0.95$1.31$8.26 billion$8.31 billionTranscript
10/16/2019Q3 2019$0.84$0.84$1.15$8.10 billion$8.08 billionTranscript
7/17/2019Q2 19$0.80$0.82$1.08$8.00 billion$7.98 billionTranscript
4/17/20193/31/2019$0.61$0.63$0.88$7.49 billion$7.54 billionListen
1/23/201912/31/2018$0.81$0.81$1.25$7.82 billion$7.77 billionListen
10/17/20189/30/2018$0.75$0.75$1.18$7.65 billion$7.66 billionTranscript
7/18/20186/30/2018$0.71$0.73$1.05$7.71 billion$7.77 billionN/A
4/18/2018Q1 18$0.58$0.59$0.95$7.28 billion$7.39 billionN/A
1/24/2018Q4 2017$0.73$0.74$1.96$7.38 billion$7.59 billionTranscript
10/18/20179/30/2017$0.65$0.66$0.98$6.72 billion$6.83 billionN/A
7/20/2017Q2 2017$0.60$0.62$1.08$6.63 billion$6.64 billionN/A
4/19/20173/31/2017$0.43$0.48$0.72$6.16 billion$6.34 billionN/A
1/25/2017Q416$0.64$0.65$0.77$5.41 billion$5.33 billionListen
10/19/2016Q316$0.58$0.59$1.40$5.29 billion$5.30 billionListen
7/20/2016Q216$0.53$0.55$0.69$5.24 billion$5.30 billionListen
4/20/2016Q116$0.39$0.41$0.61$4.77 billion$4.90 billionListen
1/28/2016Q415$0.61$0.62$0.73$5.31 billion$5.20 billionListen
10/21/2015Q315$0.53$0.54$0.70$5.16 billion$5.15 billionListen
7/22/2015Q215$0.50$0.52$0.52$5.15 billion$5.20 billionListen
4/22/2015Q115$0.42$0.47($0.57)$4.85 billion$4.90 billionListen
1/29/2015Q414$0.68$0.71$0.83$5.48 billion$5.36 billionListen
10/22/2014Q314$0.60$0.62$0.88$5.62 billion$5.10 billionListen
7/16/2014Q214$0.51$0.54$0.78$5.53 billion$5.55 billionListen
4/16/2014Q114$0.36$0.41$0.58$5.29 billion$5.24 billionListen
1/22/2014Q4 2013$0.58$0.58$0.79$5.72 billion$5.66 billionListen
10/16/2013Q3 2013$0.51$0.55$0.49$5.46 billion$5.37 billionListen
7/17/2013Q2 2013$0.44$0.46$0.62$5.53 billion$5.45 billionListen
4/17/2013Q1 2013$0.42$0.42$0.50$5.42 billion$5.38 billionListen
1/23/2013Q4 2012$1.50$1.51$10.58 billion$10.80 billionListen
10/17/2012$1.28$1.30N/A
7/18/2012$1.22$1.23N/A
4/18/2012$1.00$1.03N/A
1/25/2012$1.44$1.45N/A
10/19/2011$1.17$1.18N/A
7/20/2011$1.12$1.12N/A
4/20/2011$0.90$0.91N/A
1/26/2011$1.29$1.30Transcript
10/20/2010Q3 2010$1.04$1.05$1.53N/A
7/21/2010Q2 2010$1.00$1.01$1.19N/A
4/21/2010Q1 2010$0.80$0.81$0.98N/A
1/27/2010Q4 2009$1.17$1.18$1.38N/A
10/14/2009Q3 2009$0.90$0.92$0.89N/A
7/15/2009Q2 2009$0.89$0.90$0.97N/A
4/15/2009Q1 2009$0.70$0.73$0.54N/A
1/21/2009Q4 2008$1.06$1.06$1.14N/A
10/15/2008Q3 2008$0.77$0.79$0.89N/A
7/16/2008Q2 2008$0.78$0.84$0.83N/A
4/16/2008Q1 2008$0.63$0.63$0.66N/A
1/23/2008Q4 2007$0.92$0.93$1.09N/A
(Earnings results data provided by Zacks Investment Research)
This page was last updated on 3/6/2021 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.